SDEVNYSEFinance ServicesFiscal year ends December 31
Stablecoin Development Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$0.84−0.04 (-4.81%)
Close on Oct 19, 2026
- Market cap
- $26.03M
- P/E (TTM)
- –
- Dividend yield
- 477.10%
Stablecoin Development Corp revenue by segment
By business segment
| Revenue | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | TTM Q3 22 | TTM Q2 22 | TTM Q1 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optical and Wound Care [Member] | – | – | – | – | $11.17M | $10.95M | $10.97M | $10.35M | $10.24M | $10.17M | $9.93M | $9.15M | – | – |
| Skin Care [Member] | – | – | – | – | $3.55M | $3.70M | $4.23M | $3.91M | $4.17M | – | – | – | – | – |
| Skincare [Member] | – | – | – | – | – | – | – | – | – | $3.39M | $2.07M | $1.48M | – | – |
| Operating income | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | TTM Q3 22 | TTM Q2 22 | TTM Q1 22 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optical and Wound Care [Member] | – | – | – | – | -$3.65M | -$5.14M | -$4.69M | -$4.94M | -$5.65M | -$6.62M | -$8.65M | -$9.20M | – |
| Skin Care [Member] | – | – | – | – | -$3.95M | -$8.50M | -$8.28M | -$8.83M | -$8.77M | – | – | – | – |
By product or service
| Revenue | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | TTM Q3 22 | TTM Q2 22 | TTM Q1 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $9.75M | $9.56M | $9.61M | $10.75M | $10.46M | $11.96M | $13.30M | $13.44M | $14.37M | $13.91M | $12.35M | $10.82M | 33.3% | -6.8% |
| Total Product Revenue [Member] | $9.75M | $9.56M | $9.61M | $10.75M | $10.46M | $11.96M | $13.30M | $13.44M | $14.37M | $13.91M | $12.35M | $10.82M | 33.3% | -6.8% |
| Avenova Spray [Member] | $8.67M | $8.44M | $8.33M | $7.96M | $7.81M | $7.63M | $7.51M | $7.75M | $7.65M | $7.99M | $8.19M | $8.07M | 29.7% | +11.1% |
| Other Products [member] | $1.07M | $1.47M | $1.63M | $2.09M | $1.27M | $1.92M | $2.07M | $1.75M | $1.59M | $1.31M | $868.00K | $538.00K | 3.7% | -15.6% |
| NeutroPhase [Member] | $0 | – | – | – | $1.38M | $1.36M | $1.36M | $828.00K | $976.00K | $850.00K | $850.00K | $516.00K | 0.0% | -100.0% |
| Product and Service, Other [Member] | – | $48.00K | $41.00K | $39.00K | $0 | $40.00K | $40.00K | $31.00K | $30.00K | $23.00K | $19.00K | $24.00K | – | – |
| Avenova Direct [Member] | – | – | – | – | – | $5.90M | $5.90M | $5.90M | $6.50M | $7.50M | $7.10M | $7.10M | – | – |
| DERMAdoctor [Member] | – | – | – | – | $3.55M | $3.69M | $4.22M | $3.90M | $4.16M | $3.76M | $2.44M | $1.69M | – | – |
| Avenova Product [Member] | – | – | – | – | – | – | – | – | $6.50M | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Stablecoin Development's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.